로그인 회원가입
icon_bulk_order대량 주문 Acrobiosystems for English
0
장바구니가 비어 있습니다
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: > PSGL-1

PSGL-1

요약

Name:P-selectin glycoprotein ligand-1
Target Synonym:P-selectin glycoprotein ligand 1,PSGL-1,SELPLG,Selectin P Ligand,Cutaneous Lymphocyte-Associated Associated Antigen,CD162 Antigen,CD162,PSGL1,CLA
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:4
Lastest Research Phase:Phase 2 Clinical

제품 리스트 구매

일부의 생물활성 데이터

PS1-H52H9-BLI
Human_FcRn_Heterodimer_Protein_SPR

Human PSGL-1, His Tag (Cat. No. PS1-H52H9) immobilized on CM5 Chip can bind Human B7-H5, Fc Tag (Cat. No. B75-H5259) with an affinity constant of 0.213 μM as determined in a SPR assay (Biacore T200) (Routinely tested).

Synonym Name

PSGL1,CD162,SELPLG,Selectin P ligand

Background

P-selectin glycoprotein ligand 1 (PSGL-1) is also known as Selectin P ligand (SELPLG), CD antigen CD162. PSGL-1 is disulfide-linked homodimer which is the high affinitycounter-receptor for P-selectin on expressed on activated endothelial cells and platelets. PSGL-1 / SELPLG  interacts with P-, E- and L-selectins, through their lectin/EGF domains, is required for promoting recruitment and rolling of leukocytes. These interactions require sialyl Lewis X glycan modification but there is a differing dependence for tyrosine sulfations. Dimerization appears not to be required for P-selectin/SELP binding. PSGL-1 can interact with SNX20, MSN and SYK. PSGL-1 / SELPLG mediate the activation of SYK by SELPLG.

Clinical and Translational Updates

임상 약품 정보

Name Research Code Research Phase Company Indications Clinical Trials
Leiolizumab ALTB-268; AbGn-168H2; AbGn 168H2; AbGn-268 Phase 2 Clinical Altrubio Inc Colitis, Ulcerative Details
SSGJ-617 SSGJ-617; SSGJ617; 61X; VTX-0811 Phase 1 Clinical Sunshine Guojian Pharmaceutical (Shanghai) Co Ltd, Verseau Therapeutics Inc Solid tumours Details
Neihulizumab AbGn-168; AbGn-168H Phase 1 Clinical Abgenomics Graft vs Host Disease; Psoriasis; Colitis, Ulcerative; Arthritis, Psoriatic Details
Cepeprubart SelK-2 Phase 2 Clinical Selexys Venous Thromboembolism; Asthma; Pulmonary Disease, Chronic Obstructive Details

This web search service is supported by Google Inc.

totop